Related Experiment Video
Updated: Oct 31, 2025

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
3.3K
Pectoral Nerve Blocks for Breast Augmentation Surgery: A Randomized, Double-blind, Dual-centered Controlled Trial
Anesthesiology
|July 1, 2021
Summary
Pectoral nerve blocks significantly reduce pain and opioid use after aesthetic breast augmentation surgery. This technique offers effective pain management, improving patient recovery during the initial postoperative days.
Area of Science:
- Anesthesiology
- Pain Management
- Plastic Surgery
Background:
- Pectoral nerve blocks are explored for breast surgery analgesia, but evidence in aesthetic procedures is conflicting.
- This study investigated the efficacy of pectoral nerve blocks for pain control following breast augmentation.
Purpose of the Study:
- To determine if preincisional pectoral nerve blocks improve pain control compared to standard multimodal analgesia alone after breast augmentation.
- To assess the impact of pectoral nerve blocks on reducing rescue opioid consumption and its duration.
Main Methods:
- A randomized trial involving 73 adult female patients undergoing aesthetic breast augmentation.
- Patients were allocated to receive either a pectoral nerve block or no block, alongside standard multimodal analgesia.
- Pain scores (Numerical Rating Scale), opioid consumption, and side effects were monitored post-extubation up to day 5.
Main Results:
- The pectoral nerve block group reported significantly lower maximal pain scores in the first 6 hours post-extubation (3.9 vs. 5.2, P=0.036).
- Lower pain scores were also observed between postoperative days 1 and 5 (2.2 vs. 3.2, P=0.032).
- Opioid consumption was substantially reduced in the pectoral nerve block group from hour 6 to day 5 (P=0.006 and P=0.002, respectively).
Conclusions:
- Pectoral nerve blocks, combined with multimodal analgesia, provide effective perioperative pain relief for aesthetic breast surgery.
- This approach significantly decreases opioid requirements in the initial 5 days after surgery.

